Journal Report

Farmakoekonomika

Download PDF
Journal Information
Journal Title
Farmakoekonomika
Publisher
IRBIS LLC
ISSN
2070-4909
E-ISSN
2070-4933
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓
2025 ✓
2024 ✓
2023 ✓
2021/2022
2020
2019
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Russian EQ-5D-3L value set: population norms for the utility index in adults
N. Z. Musina, D. G. Shchurov, D. V. Blinov
2026-10-29 Vol. 19 Issue 3 Pages 463-474
DOI: 10.17749/2070-4909/farmakoekonomika.2026.420
Comparative analysis of the elemental composition and organoleptic properties of magnesium-containing vitamin-mineral complexes
O. A. Gromova, I. Yu. Torshin, M. A. Rogozin et al.
2026-10-29 Vol. 19 Issue 3 Pages 531-543
DOI: 10.17749/2070-4909/farmakoekonomika.2026.397
Criteria for monitoring the effectiveness of pharmacotherapy in patients with spinal muscular atrophy and progressive Duchenne muscular dystrophy receiving treatment through the Krug Dobra Foundation
V. V. Omelyanovskiy, P. A. Mukhortova, T. S. Teptsova et al.
2026-10-29 Vol. 19 Issue 3 Pages 486-505
DOI: 10.17749/2070-4909/farmakoekonomika.2026.409
Looking ahead: new approaches to the diagnosis, treatment, and rehabilitation of patients with deep infiltrating endometriosis
S. V. Khlopkova, A. Yu. Shatilina, N. A. Martirosyan et al.
2026-10-29 Vol. 19 Issue 3 Pages 617-626
DOI: 10.17749/2070-4909/farmakoekonomika.2026.401
Pharmacoeconomic impact of empagliflozin in patients with chronic kidney disease
D. A. Kristeleva, I. N. Dyakov, S. K. Zyryanov
2026-10-29
DOI: 10.17749/2070-4909/farmakoekonomika.2026.399
Dissecting fake news and violations of scientific ethics in scientific publications: analysis of the article “Hyperglycosylation is a metabolic driver of Alzheimer's disease”
I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova
2026-10-29 Vol. 19 Issue 3 Pages 627-644
DOI: 10.17749/2070-4909/farmakoekonomika.2026.406
Clinical and economic evaluation of transcatheter edge-to-edge repair with the TriClip system in patients with severe tricuspid regurgitation at high surgical risk in the Russian healthcare system
L. O. Krekhtunova, K. I. Matrenin, T. S. Teptsova et al.
2026-10-29 Vol. 19 Issue 3 Pages 439-450
DOI: 10.17749/2070-4909/farmakoekonomika.2026.415
COVID-19-associated coagulopathy and its role in gastroduodenal ulceration
K. A. Kammaev, T. V. Khorobrykh, D. D. Protsenko et al.
2026-10-7 Vol. 19 Issue 3 Pages 591-600
DOI: 10.17749/2070-4909/farmakoekonomika.2026.413
Evaluation of high-technology medicines considering budget impact and societal value: a three-tier approach using incretin-based therapy as an example
А. А. Lee, D. О. Borisov, V. S. Novikova et al.
2026-10-5
DOI: 10.17749/2070-4909/farmakoekonomika.2026.412
Content analysis of the range of anthelmintic drugs on the pharmaceutical market of the Republic of Uzbekistan, 2016–2025
M. M. Shakirov, Sh. Z. Umarova, A. A. Rakhimov
2026-10-1 Vol. 19 Issue 3 Pages 570-579
DOI: 10.17749/2070-4909/farmakoekonomika.2026.365
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 6, 2026 10:52